Research Worth Reading
Short summaries of papers on tumor segmentation, spine alignment, aneurysm risk, robotics, navigation, and outcomes modeling.
Industry intelligence for surgical AI
Neurosurgery.ai
Tracking the research, companies, tools, and clinical adoption signals shaping AI in neurosurgery.
Weekly signal for clinicians, founders, researchers, and investors.
Starting point
Build authority before building regulated software.
The first version is an editorial and data platform: focused, useful, and low risk. It creates a professional audience before any clinical product work begins.
Neurosurgery AI Brief
A weekly briefing with clinical signal.
Company And Tool Tracking
A structured watchlist of AI-enabled tools, regulatory status, modality, clinical use case, and adoption evidence.
Adoption Intelligence
Notes on hospital pilots, procurement signals, clinical workflow friction, reimbursement, and validation quality.
Neurosurgery.ai Index
The first data asset is a curated tool tracker.
Start with a public database, then turn the cleanest parts into a premium research product once demand is visible.
| Category | Use Case | Tracked Fields | Audience |
|---|---|---|---|
| Imaging AI | Segmentation, detection, triage | Modality, evidence, regulatory status | Clinicians, hospitals, founders |
| Surgical Planning | Pre-op planning, simulation, navigation | Workflow fit, integrations, claims | Hospitals, medtech, investors |
| Spine AI | Alignment, measurement, outcomes | Use case, validation, adoption signals | Surgeons, device companies |
Editorial tracks
Specific beats beat generic AI content.
Important boundary
No diagnosis. No patient advice. No image interpretation service.
Neurosurgery.ai begins as a professional information platform. It does not provide medical advice, clinical decision support, or patient care.
Next step
Invite the first collaborators.
Start with interviews and a small advisory circle: neurosurgeons, researchers, AI founders, hospital innovation teams, and medtech BD.